Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

S1 Data - by Miki Doi (15347878)

Subjects:

S1 Fig - by Miki Doi (15347878)

Subjects:

Semiannual analysis of monthly use of sterile blood transfer devices. by Miki Doi (15347878)

Subjects:

Semiannual analysis of monthly use of skin disinfection swab sets in the hospital. by Miki Doi (15347878)

Subjects:

Changes in the monthly contamination rate (per set) in blood culture (BC). by Miki Doi (15347878)

Subjects:

Chlorophyll a content (A), Chlorophyll b content (B), total Chlorophyll content(C), and Chlorophyll ratio (D) of M. stenopetala leaves under the effect of different PEG concentrati... by Nadia Khater (22553166)

Subjects:

Table 1_Fertilization decreases the effect of ammonium nitrogen on microorganisms in Chinese Carex tibetikobresia meadows during rest-grazing.docx by Xuanbo Zhou (19374205)

The PP1/PP2A inhibitor calyculin A increases phosphorylated Ser295 of PSD-95 concomitantly with the activation of JNK1. by Takahiko Chimura (729098)

Sociodemographic characteristics. by Hea Ree Park (10769827)

Subjects:

Study flow chart. by Hea Ree Park (10769827)

Subjects:

Association between pack years of smoking and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline analysis. by Erfan Tasdighi (9144667)

Subjects:

Distance-based redundancy analysis (dbRDA) plot performed from the distance-based linear model permutation test (DistLM) that describes the aggregation of sampling stations at ever... by Francisco Flores-de-Santiago (20391063)

Tourism determinants’ marginal effects. by Sakar Hasan Hamza (20978818)

Subjects:

Descriptive statistics from 2005 to 2018. by Sakar Hasan Hamza (20978818)

Subjects:

Models 7 to 12: estimation results. by Sakar Hasan Hamza (20978818)

Subjects:

Models 1 to 6: estimation results. by Sakar Hasan Hamza (20978818)

Subjects:

Hausman test results. by Sakar Hasan Hamza (20978818)

Subjects: